Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00262470 · ClinicalTrials.gov registry record · Phase 1
Treatment of Orthostatic Intolerance
A Phase 1 study of Tachycardia and Chronic Orthostatic Intolerance, sponsored by Satish R. Raj.
- Active
- Registry status
- Phase 1
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT00262470: Active Phase 1 study of Tachycardia and Chronic Orthostatic Intolerance, sponsored by Satish R. Raj.
NCT00262470 is a Phase 1 study of Tachycardia and Chronic Orthostatic Intolerance that is active but no longer recruiting, run by Satish R. Raj. The registered enrollment target is 150 participants, below the 880-participant average among 8 other Tachycardia trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00262470, a Phase 1 study of Tachycardia and Chronic Orthostatic Intolerance, is active but no longer recruiting, sponsored by Satish R. Raj.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic intolerance in patients with this disorder.
Conditions Studied
Interventions
- DRUG Acetazolamide
- DRUG Atomoxetine
- DRUG Clonidine
- OTHER NO Drug
- DRUG Entacapone
Study Locations (1)
Tennessee
- Vanderbilt University Autonomic Dysfunction Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 1997-04 |
| Est. Completion | 2029-12 |
| Phase | Phase 1 |
What the registry record for NCT00262470 still lists
NCT00262470 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 880-participant average among 8 other Tachycardia trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Tachycardia appearing as the primary indexed condition, and to 5 interventions - of which Acetazolamide is the first listed.
NCT00262470 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00262470 about?
NCT00262470 is a clinical study titled "Treatment of Orthostatic Intolerance". This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic intolerance in patients with this disorder.
What is the current status of trial NCT00262470?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 1997-04. Estimated completion is 2029-12.
What conditions does trial NCT00262470 study?
This clinical trial studies the following conditions: Tachycardia, Chronic Orthostatic Intolerance.
What interventions are being tested in trial NCT00262470?
The interventions under investigation include: Acetazolamide (DRUG), Atomoxetine (DRUG), Clonidine (DRUG), NO Drug (OTHER), Entacapone (DRUG).
Who is sponsoring clinical trial NCT00262470?
This trial is sponsored by Satish R. Raj, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00262470 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00262470's enrollment target sits among peer trials
150 9th of 8 the lowest of 8 other Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
ACTIVE NOT RECRUITING
-
Enlighten Study: The EV-ICD Post Approval Registry
ACTIVE NOT RECRUITING
-
Pathophysiology of Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
-
Cardiac Implantable Electronic Device (CIED) Research Study
ACTIVE NOT RECRUITING
-
RIGHT: Rhythm ID Going Head-to-Head Trial
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia